CCR5 and neoplasm: Our findings have been mirrored by a report from Dobrzanski et al. that demonstrates that the adoptive transfer of MUC1 specific CD4+ T cells increase endogenous T cell activity and the survival of patients with residual recurrent epithelial ovarian cancer, and that these effects corresponded with increased expression of CCR5 and associated ligands on tumor responsive T cells [113].